ROYAL BANK OF CANADA - VOYAGER THERAPEUTICS INC ownership

VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 121 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of VOYAGER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$50,000
-63.8%
6,477
-45.9%
0.00%
Q2 2023$138,000
+48.4%
11,972
-0.3%
0.00%
Q1 2023$93,000
+25.7%
12,007
-1.8%
0.00%
Q4 2022$74,000
+4.2%
12,221
+1.8%
0.00%
Q3 2022$71,000
+1675.0%
12,004
+1746.8%
0.00%
Q2 2022$4,000
-20.0%
6500.0%0.00%
Q1 2022$5,000
+150.0%
6500.0%0.00%
Q4 2021$2,0000.0%6500.0%0.00%
Q3 2021$2,000
-92.0%
650
-89.1%
0.00%
Q2 2021$25,000
+127.3%
5,937
+160.7%
0.00%
Q1 2021$11,000
-15.4%
2,277
+25.8%
0.00%
Q4 2020$13,000
-72.3%
1,810
-59.0%
0.00%
Q3 2020$47,000
-14.5%
4,410
+1.9%
0.00%
Q2 2020$55,000
+34.1%
4,326
-3.0%
0.00%
Q1 2020$41,000
-56.8%
4,460
-34.2%
0.00%
Q4 2019$95,000
+10.5%
6,778
+35.7%
0.00%
Q3 2019$86,000
-26.5%
4,995
+15.9%
0.00%
Q2 2019$117,000
+42.7%
4,310
+1.5%
0.00%
Q1 2019$82,000
-43.1%
4,248
-72.4%
0.00%
Q4 2018$144,000
-70.7%
15,380
-40.8%
0.00%
Q3 2018$492,000
+1161.5%
25,970
+1189.5%
0.00%
Q2 2018$39,000
+30.0%
2,014
+25.1%
0.00%
Q1 2018$30,000
-38.8%
1,610
-32.0%
0.00%
Q3 2017$49,000
+4800.0%
2,368
+1794.4%
0.00%
Q2 2017$1,000
-83.3%
125
-71.7%
0.00%
Q1 2017$6,000
-45.5%
441
-48.5%
0.00%
Q4 2016$11,000856
+17020.0%
0.00%
Q3 2016$050.00%
Other shareholders
VOYAGER THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
TRV GP III, LLC 7,891,176$154,194,00051.35%
Trustees of Princeton University 203,638$3,979,0004.13%
Casdin Capital, LLC 1,135,000$22,178,0003.10%
GREAT POINT PARTNERS LLC 730,010$14,264,0001.98%
BB BIOTECH AG 2,532,641$49,488,0001.43%
Aevitas Wealth Management, Inc. 73,323$1,433,0001.40%
Patriot Financial Group Insurance Agency, LLC 64,256$1,256,0001.34%
Virtus ETF Advisers LLC 37,502$733,0000.65%
Eventide Asset Management 703,425$13,745,0000.57%
THOMPSON DAVIS & CO., INC. 11,951$234,0000.56%
View complete list of VOYAGER THERAPEUTICS INC shareholders